Showing results for:
Drug name(s)
Neupogen® Filgrastim G-CSF Zarxio™ * Filgrastim-sndz* Nivestym™ * Filgrastim-aafi* Releuko* Filgrastim-ayow*
Approved for
- Leukemia
- Acute Myeloid Leukemia (AML)
- Other Blood Cancers
Drug name(s)
Zarxio® Filgrastim-sndz
Approved for
- Leukemia
- Acute Myeloid Leukemia (AML)
- Other Blood Cancers
Drug name(s)
Zevalin® Ibritumomab tiuxetan
Approved for
- Lymphoma
- Non-Hodgkin Lymphoma (NHL)
Drug name(s)
Zydelig® Idelalisib
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
Drug name(s)
Zynlonta™ Loncastuximab tesirine-lpyl
Approved for
- Lymphoma
- Diffuse Large B-cell Lymphoma (DLBCL)
- High-grade B-cell Lymphoma with double or triple hits (HBL)
Drug name(s)
Neulasta® Pegfilgrastim G-CSF Fulphila™ * Pegfilgrastim-jmdb* Udenyca™ * Pegfilgrastim-cbqv* Ziextenzo™ * Pegfilgrastim-bmez * Nyvepria Pegfilgrastim-apgf* Fylnetra* Pegfilgrastim-pbbk* Stimufend®* Pegfilgrastim-fpgk*
Approved for
- Other Blood Cancers
Drug name(s)
Zelboraf® Vemurafenib
Approved for
- Other Blood Cancers
Drug name(s)
Zolinza® Vorinostat
Approved for
- Lymphoma
- Cutaneous T-cell Lymphoma (CTCL)
Drug name(s)
Brukinsa® Zanubrutinib
Approved for
- Leukemia
- Chronic Lymphocytic Leukemia (CLL/SLL)
- Lymphoma
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Waldenström Macroglobulinemia (WM)
Drug name(s)
Komzifti™ Ziftomenib
Approved for
- Acute Myeloid Leukemia (AML)
Drug name(s)
Zometa® Zoledronic acid
Approved for
- Myeloma
- Other Blood Cancers